Search

Your search keyword '"Ethun, Cecilia G."' showing total 401 results
Start Over Author "Ethun, Cecilia G."
401 results on '"Ethun, Cecilia G."'

4. Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms

Author

Squires, Malcolm Hart, Ethun, Cecilia G., Donahue, Erin E., Benbow, Jennifer H., Anderson, Colin J., Jagosky, Megan H., Manandhar, Munsa, Patt, Joshua C., Kneisl, Jeffrey S., Salo, Jonathan C., Hill, Joshua S., Ahrens, William, Prabhu, Roshan S., Livingston, Michael B., Gower, Nicole L., Needham, McKenzie, Trufan, Sally J., Fields, Ryan C., Krasnick, Bradley A., Bedi, Meena, Votanopoulos, Konstantinos, Chouliaras, Konstantinos, Grignol, Valerie, Roggin, Kevin K., Tseng, Jennifer, Poultsides, George, Tran, Thuy B., Cardona, Kenneth, and Howard, J. Harrison

Published
2022
Full Text
View/download PDF

5. A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group

Author

Poorman, Caroline E, Ethun, Cecilia G, Postlewait, Lauren M, Tran, Thuy B, Prescott, Jason D, Pawlik, Timothy M, Wang, Tracy S, Glenn, Jason, Hatzaras, Ioannis, Shenoy, Rivfka, Phay, John E, Keplinger, Kara, Fields, Ryan C, Jin, Linda X, Weber, Sharon M, Salem, Ahmed, Sicklick, Jason K, Gad, Shady, Yopp, Adam C, Mansour, John C, Duh, Quan-Yang, Seiser, Natalie, Solórzano, Carmen C, Kiernan, Colleen M, Votanopoulos, Konstantinos I, Levine, Edward A, Staley, Charles A, Poultsides, George A, and Maithel, Shishir K

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Clinical Research, Adrenal Cortex Neoplasms, Adrenalectomy, Adrenocortical Carcinoma, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Retrospective Studies, Risk Factors, Survival Rate, Treatment Outcome, Tumor Burden, United States, Oncology and Carcinogenesis, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract

BACKGROUND:The 7th AJCC T-stage system for adrenocortical carcinoma (ACC), based on size and extra-adrenal invasion, does not adequately stratify patients by survival. Lymphovascular invasion (LVI) is a known poor prognostic factor. We propose a novel T-stage system that incorporates LVI to better risk-stratify patients undergoing resection for ACC. METHOD:Patients undergoing curative-intent resections for ACC from 1993 to 2014 at 13 institutions comprising the US ACC Group were included. Primary outcome was disease-specific survival (DSS). RESULTS:Of the 265 patients with ACC, 149 were included for analysis. The current T-stage system failed to differentiate patients with T2 versus T3 disease (p = 0.10). Presence of LVI was associated with worse DSS versus no LVI (36 mo vs. 168 mo; p = 0.001). After accounting for the individual components of the current T-stage system (size, extra-adrenal invasion), LVI remained a poor prognostic factor on multivariable analysis (hazard ratio 2.14, 95% confidence interval 1.05-4.38, p = 0.04). LVI positivity further stratified patients with T2 and T3 disease (T2: 37 mo vs. median not reached; T3: 36 mo vs. 96 mo; p = 0.03) but did not influence survival in patients with T1 or T4 disease. By incorporating LVI, a new T-stage classification system was created: [T1: ≤ 5 cm, (-)local invasion, (+/-)LVI; T2: > 5 cm, (-)local invasion, (-)LVI OR any size, (+)local invasion, (-)LVI; T3: > 5 cm, (-)local invasion, (+)LVI OR any size, (+)local invasion, (+)LVI; T4: any size, (+)adjacent organ invasion, (+/-)LVI]. Each progressive new T-stage group was associated with worse median DSS (T1: 167 mo; T2: 96 mo; T3: 37 mo; T4: 15 mo; p

Published
2018

6. Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative

Author

Makris, Eleftherios A., primary, Tran, Thuy B., additional, Delitto, Daniel J., additional, Lee, Byrne, additional, Ethun, Cecilia G., additional, Grignol, Valerie, additional, Harrison Howard, J., additional, Bedi, Meena, additional, Clark Gamblin, T., additional, Tseng, Jennifer, additional, Roggin, Kevin K., additional, Chouliaras, Konstantinos, additional, Votanopoulos, Konstantinos, additional, Cullinan, Darren, additional, Fields, Ryan C., additional, Cardona, Kenneth, additional, Poultsides, George, additional, and Kirane, Amanda, additional

Published
2024
Full Text
View/download PDF

8. Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group

Author

Poorman, Caroline E, Postlewait, Lauren M, Ethun, Cecilia G, Tran, Thuy B, Prescott, Jason D, Pawlik, Timothy M, Wang, Tracy S, Glenn, Jason, Hatzaras, Ioannis, Shenoy, Rivfka, Phay, John E, Keplinger, Kara, Fields, Ryan C, Jin, Linda X, Weber, Sharon M, Salem, Ahmed, Sicklick, Jason K, Gad, Shady, Yopp, Adam C, Mansour, John C, Duh, Quan-Yang, Seiser, Natalie, Solorzano, Carmen C, Kiernan, Colleen M, Votanopoulos, Konstantinos I, Levine, Edward A, Staley, Charles A, Poultsides, George A, and Maithel, Shishir K

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Trials and Supportive Activities, Basic Behavioral and Social Science, Digestive Diseases, Cancer, Rare Diseases, Clinical Research, Behavioral and Social Science, 6.4 Surgery, Evaluation of treatments and therapeutic interventions, Adrenal Cortex Neoplasms, Adrenocortical Carcinoma, Blood Transfusion, Female, Humans, Male, Middle Aged, Prognosis, Proportional Hazards Models, Retrospective Studies, Survival Rate, United States, Surgery, Clinical sciences
Abstract

Perioperative blood transfusion is associated with decreased survival in pancreatic, gastric, and liver cancer. The effect of transfusion in adrenocortical carcinoma (ACC) has not been studied. Patients with available transfusion data undergoing curative-intent resection of ACC from 1993 to 2014 at 13 institutions comprising the United States Adrenocortical Carcinoma Group were included. Factors associated with blood transfusion were determined. Primary and secondary end points were recurrence-free survival (RFS) and overall survival (OS), respectively. Out of 265 patients, 149 were included for analysis. Out of these, 57 patients (38.3%) received perioperative transfusions. Compared to nontransfused patients, transfused patients more commonly had stage 4 disease (46% vs 24%, P = 0.01), larger tumors (15.8 vs 10.2 cm, P < 0.001), inferior vena cava involvement (24.6% vs 5.4%, P = 0.002), additional organ resection (78.9% vs 36.3%, P < 0.001), and major complications (29% vs 2%, P < 0.001). Transfusion was associated with decreased RFS (8.9 vs 24.7 months, P = 0.006) and OS (22.8 vs 91.0 months, P < 0.001). On univariate Cox regression, transfusion, stage IV, hormonal hypersecretion, and adjuvant therapy were associated with decreased RFS. On multivariable analysis, only transfusion [hazard ratio (HR) = 1.7, 95% confidence interval (CI) =1.0-2.9, P = 0.04], stage IV (HR = 3.2, 95% CI = 1.7-5.9, P < 0.001), and hormonal hypersecretion (HR = 2.6, 95% CI = 1.5-4.2, P < 0.001) were associated with worse RFS. When applying this model to OS, similar associations were seen (transfusion HR = 2.0, 95% CI = 1.1-3.8, P = 0.02; stage 4 HR = 6.2, 95% CI = 3.1-12.4, P < 0.001; hormonal hypersecretion HR = 3.5, 95% CI = 1.9-6.4, P < 0.001). There was no difference in outcomes between patients who received 1 to 2 units versus >2 units of packed red blood cells in median RFS (8.9 vs 8.4 months, P = 0.95) or OS (26.5 vs 18.6 months, P = 0.63). Perioperative transfusion is associated with earlier recurrence and decreased survival after curative-intent resection of ACC. Strategies and protocols to minimize blood transfusion should be developed and followed.

Published
2017

12. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma

Author

Strong, Erin A., Park, Sandra H., Ethun, Cecilia G., Chow, Bonnie, King, David, Bedi, Meena, Charlson, John, Mogal, Harveshp, Tsai, Susan, Christians, Kathleen, Tran, Thuy B., Poultsides, George, Grignol, Valerie, Howard, J. Harrison, Tseng, Jennifer, Roggin, Kevin K., Chouliaras, Konstantinos, Votanopoulos, Konstantinos, Cullinan, Darren, Fields, Ryan C., Gamblin, T. Clark, Cardona, Kenneth, and Clarke, Callisia N.

Published
2020
Full Text
View/download PDF

13. A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multi-institutional analysis from the US Sarcoma Collaborative

Author

Lee, Rachel M., Ethun, Cecilia G., Zaidi, Mohammad Y., Tran, Thuy B., Poultsides, George A., Grignol, Valerie P., Howard, John H., Bedi, Meena, Gamblin, T. Clark, Tseng, Jennifer, Roggin, Kevin K., Chouliaras, Konstantinos, Votanopoulos, Konstantinos, Krasnick, Bradley A., Fields, Ryan C., Oskouei, Shervin V., Monson, David K., Reimer, Nickolas B., Maithel, Shishir K., and Cardona, Kenneth

Published
2020
Full Text
View/download PDF

15. Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.

Author

Postlewait, Lauren M, Ethun, Cecilia G, Tran, Thuy B, Prescott, Jason D, Pawlik, Timothy M, Wang, Tracy S, Glenn, Jason, Hatzaras, Ioannis, Shenoy, Rivfka, Phay, John E, Keplinger, Kara, Fields, Ryan C, Jin, Linda X, Weber, Sharon M, Salem, Ahmed, Sicklick, Jason K, Gad, Shady, Yopp, Adam C, Mansour, John C, Duh, Quan-Yang, Seiser, Natalie, Solorzano, Carmen C, Kiernan, Colleen M, Votanopoulos, Konstantinos I, Levine, Edward A, Staley, Charles A, Poultsides, George A, and Maithel, Shishir K

Subjects
Humans, Adrenocortical Carcinoma, Adrenal Cortex Neoplasms, Mitotane, Antineoplastic Agents, Hormonal, Disease-Free Survival, Treatment Outcome, Chemotherapy, Adjuvant, Adrenalectomy, Retrospective Studies, Adult, Aged, Middle Aged, United States, Female, Male, Cancer, Clinical Trials and Supportive Activities, Clinical Research, Patient Safety, 6.1 Pharmaceuticals, Surgery, Clinical Sciences
Abstract

BackgroundCurrent treatment guidelines recommend adjuvant mitotane after resection of adrenocortical carcinoma with high-risk features (eg, tumor rupture, positive margins, positive lymph nodes, high grade, elevated mitotic index, and advanced stage). Limited data exist on the outcomes associated with these practice guidelines.Study designPatients who underwent resection of adrenocortical carcinoma from 1993 to 2014 at the 13 academic institutions of the US Adrenocortical Carcinoma Group were included. Factors associated with mitotane administration were determined. Primary end points were recurrence-free survival (RFS) and overall survival (OS).ResultsOf 207 patients, 88 (43%) received adjuvant mitotane. Receipt of mitotane was associated with hormonal secretion (58% vs 32%; p = 0.001), advanced TNM stage (stage IV: 42% vs 23%; p = 0.021), adjuvant chemotherapy (37% vs 5%; p < 0.001), and adjuvant radiation (17% vs 5%; p = 0.01), but was not associated with tumor rupture, margin status, or N-stage. Median follow-up was 44 months. Adjuvant mitotane was associated with decreased RFS (10.0 vs 27.9 months; p = 0.007) and OS (31.7 vs 58.9 months; p = 0.006). On multivariable analysis, mitotane was not independently associated with RFS or OS, and margin status, advanced TNM stage, and receipt of chemotherapy were associated with survival. After excluding all patients who received chemotherapy, adjuvant mitotane remained associated with decreased RFS and similar OS; multivariable analyses again showed no association with recurrence or survival. Stage-specific analyses in both cohorts revealed no association between adjuvant mitotane and improved RFS or OS.ConclusionsWhen accounting for stage and adverse tumor and treatment-related factors, adjuvant mitotane after resection of adrenocortical carcinoma is not associated with improved RFS or OS. Current guidelines should be revisited and prospective trials are needed.

Published
2016

19. ASO Visual Abstract: Extremity Soft Tissue Sarcoma—A Multi-institutional Validation of Prognostic Nomograms

Author

Squires, Malcolm H., Ethun, Cecilia G., Donahue, Erin E., Benbow, Jennifer H., Anderson, Colin J., Jagosky, Megan H., Manandhar, Munsa, Patt, Joshua C., Kneisl, Jeffrey S., Salo, Jonathan C., Hill, Joshua S., Ahrens, William, Prabhu, Roshan S., Livingston, Michael B., Gower, Nicole L., Needham, McKenzie, Trufan, Sally J., Fields, Ryan C., Krasnick, Bradley A., Bedi, Meena, Votanopoulos, Konstantinos, Chouliaras, Konstantinos, Grignol, Valerie, Roggin, Kevin K., Tseng, Jennifer, Poultsides, George, Tran, Thuy B., Cardona, Kenneth, and Howard, J. Harrison

Published
2022
Full Text
View/download PDF

24. Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth?

Author

Johnson, Aileen C., Ethun, Cecilia G., Liu, Yuan, Lopez-Aguiar, Alexandra G., Tran, Thuy B., Poultsides, George, Grignol, Valerie, Howard, J. Harrison, Bedi, Meena, Gamblin, T. Clark, Tseng, Jennifer, Roggin, Kevin K., Chouliaras, Konstantinos, Votanopoulos, Konstantinos, Cullinan, Darren, Fields, Ryan C., Delman, Keith A., Wood, William C., Cardona, Kenneth, and Maithel, Shishir K.

Published
2018
Full Text
View/download PDF

25. Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium

Author

Schimizzi, Gregory V., Jin, Linda X., Davidson, Jesse T., IV, Krasnick, Bradley A., Ethun, Cecilia G., Pawlik, Timothy M., Poultsides, George, Tran, Thuy, Idrees, Kamran, Isom, Chelsea A., Weber, Sharon M., Salem, Ahmed, Hawkins, William G., Strasberg, Steven M., Doyle, Maria B., Chapman, William C., Martin, Robert C.G., Scoggins, Charles, Shen, Perry, Mogal, Harveshp D., Schmidt, Carl, Beal, Eliza, Hatzaras, Ioannis, Shenoy, Rivfka, Maithel, Shishir K., and Fields, Ryan C.

Published
2018
Full Text
View/download PDF

26. The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium

Author

Bhutiani, Neal, Scoggins, Charles R., McMasters, Kelly M., Ethun, Cecilia G., Poultsides, George A., Pawlik, Timothy M., Weber, Sharon M., Schmidt, Carl R., Fields, Ryan C., Idrees, Kamran, Hatzaras, Ioannis, Shen, Perry, Maithel, Shishir K., and Martin, Robert C.G., II

Published
2018
Full Text
View/download PDF

27. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative

Author

Zaidi, Mohammad Y., Ethun, Cecilia G., Tran, Thuy B., Poultsides, George, Grignol, Valerie P., Howard, J. Harrison, Bedi, Meena, Mogal, Harveshp, Tseng, Jennifer, Roggin, Kevin K., Chouliaras, Konstantinos, Votanopoulos, Konstantinos, Krasnick, Brad, Fields, Ryan C., Oskouei, Shervin, Reimer, Nickolas, Monson, David, Maithel, Shishir K., and Cardona, Kenneth

Published
2019
Full Text
View/download PDF

28. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium

Author

Lopez-Aguiar, Alexandra G., Ethun, Cecilia G., Pawlik, Timothy M., Tran, Thuy, Poultsides, George A., Isom, Chelsea A., Idrees, Kamran, Krasnick, Bradley A., Fields, Ryan C., Salem, Ahmed, Weber, Sharon M., Martin, Robert C. G., Scoggins, Charles R., Shen, Perry, Mogal, Harveshp D., Beal, Eliza W., Schmidt, Carl, Shenoy, Rivfka, Hatzaras, Ioannis, and Maithel, Shishir K.

Published
2019
Full Text
View/download PDF

29. Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma

Author

Tran, Thuy B., Ethun, Cecilia G., Pawlik, Timothy M., Schmidt, Carl, Beal, Eliza W., Fields, Ryan C., Krasnick, Bradley, Weber, Sharon M., Salem, Ahmed, Martin, Robert C. G., Scoggins, Charles R., Shen, Perry, Mogal, Harveshp D., Idrees, Kamran, Isom, Chelsea A., Hatzaras, Ioannis, Shenoy, Rivfka, Maithel, Shishir K., and Poultsides, George A.

Published
2019
Full Text
View/download PDF

30. Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy Consortium

Author

Beal, Eliza W., Lyon, Ezra, Kearney, Joe, Wei, Lai, Ethun, Cecilia G., Black, Sylvester M., Dillhoff, Mary, Salem, Ahmed, Weber, Sharon M., Tran, Thuy B., Poultsides, George, Shenoy, Rivfka, Hatzaras, Ioannis, Krasnick, Bradley, Fields, Ryan C., Buttner, Stefan, Scoggins, Charles R., Martin, Robert C.G., Isom, Chelsea A., Idrees, Kamron, Mogal, Harveshp D., Shen, Perry, Maithel, Shishir K., Pawlik, Timothy M., and Schmidt, Carl R.

Published
2017
Full Text
View/download PDF

31. Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases

Author

Buettner, Stefan, van Vugt, Jeroen L.A., Gaspersz, Marcia P., Coelen, Robert J.S., Roos, Eva, Labeur, Tim A., Margonis, Georgios A., Ethun, Cecilia G., Maithel, Shishir K., Poultsides, George, Tran, Thuy, Idrees, Kamran, Isom, Chelsea A., Fields, Ryan C., Krasnick, Bradley A., Weber, Sharon M., Salem, Ahmed, Martin, Robert C.G., Scoggins, Charles R., Shen, Perry, Mogal, Harveshp D., Schmidt, Carl, Beal, Eliza, Hatzaras, Ioannis, Shenoy, Rivfka, IJzermans, Jan N.M., van Gulik, Thomas M., Pawlik, Timothy M., and Groot Koerkamp, Bas

Published
2017
Full Text
View/download PDF

32. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium

Author

Ethun, Cecilia G., Lopez-Aguiar, Alexandra G., Pawlik, Timothy M., Poultsides, George, Idrees, Kamran, Fields, Ryan C., Weber, Sharon M., Cho, Clifford, Martin, Robert C., Scoggins, Charles R., Shen, Perry, Schmidt, Carl, Hatzaras, Ioannis, Bentrem, David, Ahmad, Syed, Abbott, Daniel, Kim, Hong Jin, Merchant, Nipun, Staley, Charles A., Kooby, David A., and Maithel, Shishir K.

Published
2017
Full Text
View/download PDF

34. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium

Author

Zhang, Xu-Feng, Beal, Eliza W., Chakedis, Jeffery, Chen, Qinyu, Lv, Yi, Ethun, Cecilia G., Salem, Ahmed, Weber, Sharon M., Tran, Thuy, Poultsides, George, Son, Andre Y., Hatzaras, Ioannis, Jin, Linda, Fields, Ryan C., Buettner, Stefan, Scoggins, Charles, Martin, Robert C. G., Isom, Chelsea A., Idrees, Kamron, Mogal, Harveshp D., Shen, Perry, Maithel, Shishir K., Schmidt, Carl R., and Pawlik, Timothy M.

Published
2018
Full Text
View/download PDF

35. The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma

Author

Zhang, Xu-Feng, Squires, III, Malcolm H., Bagante, Fabio, Ethun, Cecilia G., Salem, Ahmed, Weber, Sharon M., Tran, Thuy, Poultsides, George, Son, Andre Y., Hatzaras, Ioannis, Jin, Linda, Fields, Ryan C., Weiss, Matthew, Scoggins, Charles, Martin, Robert C. G., Isom, Chelsea A., Idrees, Kamron, Mogal, Harveshp D., Shen, Perry, Maithel, Shishir K., Schmidt, Carl R., and Pawlik, Timothy M.

Published
2018
Full Text
View/download PDF

36. Elevated NLR in gallbladder cancer and cholangiocarcinoma – making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium

Author

Beal, Eliza W., Wei, Lai, Ethun, Cecilia G., Black, Sylvester M., Dillhoff, Mary, Salem, Ahmed, Weber, Sharon M., Tran, Thuy, Poultsides, George, Son, Andre Y., Hatzaras, Ioannis, Jin, Linda, Fields, Ryan C., Buettner, Stefan, Pawlik, Timothy M., Scoggins, Charles, Martin, Robert C.G., Isom, Chelsea A., Idrees, Kamron, Mogal, Harveshp D., Shen, Perry, Maithel, Shishir K., and Schmidt, Carl R.

Published
2016
Full Text
View/download PDF

37. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium

Author

Margonis, Georgios Antonios, Gani, Faiz, Buettner, Stefan, Amini, Neda, Sasaki, Kazunari, Andreatos, Nikolaos, Ethun, Cecilia G., Poultsides, George, Tran, Thuy, Idrees, Kamran, Isom, Chelsea A., Fields, Ryan C., Krasnick, Bradley, Weber, Sharon M., Salem, Ahmed, Martin, Robert C.G., Scoggins, Charles, Shen, Perry, Mogal, Harveshp D., Schmidt, Carl, Beal, Eliza, Hatzaras, Ioannis, Shenoy, Rivfka, Maithel, Shishir K., and Pawlik, Timothy M.

Published
2016
Full Text
View/download PDF

38. Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium

Author

Postlewait, Lauren M., Ethun, Cecilia G., Le, Nina, Pawlik, Timothy M., Buettner, Stefan, Poultsides, George, Tran, Thuy, Idrees, Kamran, Isom, Chelsea A., Fields, Ryan C., Krasnick, Bradley, Weber, Sharon M., Salem, Ahmed, Martin, Robert C.G., Scoggins, Charles, Shen, Perry, Mogal, Harveshp D., Schmidt, Carl, Beal, Eliza, Hatzaras, Ioannis, Vitiello, Gerardo, Cardona, Kenneth, and Maithel, Shishir K.

Published
2016
Full Text
View/download PDF

39. Conditional probability of long-term survival after resection of hilar cholangiocarcinoma

Author

Buettner, Stefan, Margonis, Georgios A., Kim, Yuhree, Gani, Faiz, Ethun, Cecilia G., Poultsides, George, Tran, Thuy, Idrees, Kamran, Isom, Chelsea A., Fields, Ryan C., Krasnick, Bradley, Weber, Sharon M., Salem, Ahmed, Martin, Robert C.G., Scoggins, Charles R., Shen, Perry, Mogal, Harveshp D., Schmidt, Carl, Beal, Eliza, Hatzaras, Ioannis, Shenoy, Rivfka, Maithel, Shishir K., and Pawlik, Timothy M.

Published
2016
Full Text
View/download PDF

40. Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme

Author

Bagante, Fabio, Tran, Thuy, Spolverato, Gaya, Ruzzenente, Andrea, Buttner, Stefan, Ethun, Cecilia G., Koerkamp, Bas Groot, Conci, Simone, Idrees, Kamran, Isom, Chelsea A., Fields, Ryan C., Krasnick, Bradley, Weber, Sharon M., Salem, Ahmed, Martin, Robert C.G., Scoggins, Charles, Shen, Perry, Mogal, Harveshp D., Schmidt, Carl, Beal, Eliza, Hatzaras, Ioannis, Vitiello, Gerardo, IJzermans, Jan N.M., Maithel, Shishir K., Poultsides, George, Guglielmi, Alfredo, and Pawlik, Timothy M.

Published
2016
Full Text
View/download PDF

42. Outcomes of plastic surgical reconstruction in extremity and truncal soft tissue sarcoma: Results from the US Sarcoma Collaborative

Author

Thalji, Sam Z., primary, Ethun, Cecilia G., additional, Tsai, Susan, additional, Gamblin, T. Clark, additional, Clarke, Callisia N., additional, Bedi, Meena, additional, King, David, additional, LoGiudice, John, additional, Poultsides, George, additional, Grignol, Valerie P., additional, Tseng, Jennifer, additional, Votanopoulos, Konstantinos, additional, Fields, Ryan C., additional, Cardona, Kenneth, additional, and Mogal, Harveshp, additional

Published
2022
Full Text
View/download PDF

43. A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group

Author

Poorman, Caroline E., Ethun, Cecilia G., Postlewait, Lauren M., Tran, Thuy B., Prescott, Jason D., Pawlik, Timothy M., Wang, Tracy S., Glenn, Jason, Hatzaras, Ioannis, Shenoy, Rivfka, Phay, John E., Keplinger, Kara, Fields, Ryan C., Jin, Linda X., Weber, Sharon M., Salem, Ahmed, Sicklick, Jason K., Gad, Shady, Yopp, Adam C., Mansour, John C., Duh, Quan-Yang, Seiser, Natalie, Solórzano, Carmen C., Kiernan, Colleen M., Votanopoulos, Konstantinos I., Levine, Edward A., Staley, Charles A., Poultsides, George A., and Maithel, Shishir K.

Published
2017
Full Text
View/download PDF

45. Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies

Author

Buettner, Stefan, Ethun, Cecilia G., Poultsides, George, Tran, Thuy, Idrees, Kamran, Isom, Chelsea A., Weiss, Matthew, Fields, Ryan C., Krasnick, Bradley, Weber, Sharon M., Salem, Ahmed, Martin, Robert C. G., Scoggins, Charles R., Shen, Perry, Mogal, Harveshp D., Schmidt, Carl, Beal, Eliza, Hatzaras, Ioannis, Shenoy, Rivfka, Koerkamp, Bas Groot, Maithel, Shishir K., and Pawlik, Timothy M.

Published
2017
Full Text
View/download PDF

48. Gallbladder Cancer Presenting with Jaundice: Uniformly Fatal or Still Potentially Curable?

Author

Tran, Thuy B., Norton, Jeffrey A., Ethun, Cecilia G., Pawlik, Timothy M., Buettner, Stefan, Schmidt, Carl, Beal, Eliza W., Hawkins, William G., Fields, Ryan C., Krasnick, Bradley A., Weber, Sharon M., Salem, Ahmed, Martin, Robert C. G., Scoggins, Charles R., Shen, Perry, Mogal, Harveshp D., Idrees, Kamran, Isom, Chelsea A., Hatzaras, Ioannis, Shenoy, Rivfka, Maithel, Shishir K., and Poultsides, George A.

Published
2017
Full Text
View/download PDF

49. A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium

Author

Ethun, Cecilia G., Postlewait, Lauren M., Le, Nina, Pawlik, Timothy M., Buettner, Stefan, Poultsides, George, Tran, Thuy, Idrees, Kamran, Isom, Chelsea A., Fields, Ryan C., Jin, Linda X., Weber, Sharon M., Salem, Ahmed, Martin, Robert C. G., Scoggins, Charles, Shen, Perry, Mogal, Harveshp D., Schmidt, Carl, Beal, Eliza, Hatzaras, Ioannis, Shenoy, Rivfka, Merchant, Nipun, Cardona, Kenneth, and Maithel, Shishir K.

Published
2017
Full Text
View/download PDF

50. Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer

Author

Spolverato, Gaya, Bagante, Fabio, Ethun, Cecilia G., Poultsides, George, Tran, Thuy, Idrees, Kamran, Isom, Chelsea A., Fields, Ryan C., Krasnick, Bradley, Winslow, Emily, Cho, Clifford, Martin, Robert C. G., Scoggins, Charles R., Shen, Perry, Mogal, Harveshp D., Schmidt, Carl, Beal, Eliza, Hatzaras, Ioannis, Shenoy, Rivfka, Maithel, Shishir K., and Pawlik, Timothy M.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results